Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

8.80
Delayed Data
As of May 27
 +0.14 / +1.62%
Today’s Change
5.18
Today|||52-Week Range
11.26
-15.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues4.8M5.2M5.6M4.9M
 
 
 
 
 
Cost of Goods Sold1.0M1.2M1.2M1.1M
 
 
 
 
 
Depreciation And Amortization14.3K16.5K18.0K19.6K
 
 
 
 
 
 
Operating ExpensesGross Income3.8M4.0M4.4M3.8M
 
 
 
 
 
General Expenses31.1M23.5M21.9M24.8M
 
 
 
 
 
Research And Development24.2M16.4M13.3M15.1M
 
 
 
 
 
Total Operating Expenses32.1M24.7M23.1M25.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.3M-19.5M-17.5M-21.0M
 
 
 
 
 
Other Expenses25.6K27.6K24.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.2M-19.5M-17.5M-20.9M
 
 
 
 
 
Net Income-27.2M-19.5M-17.5M-20.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS172.8M177.2M177.9M194.9M
 
 
 
 
 
Shares To Calculate EPS Diluted172.8M177.2M177.9M194.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.11-$0.10-$0.11
 
 
 
 
 
EPS Diluted-$0.16-$0.11-$0.10-$0.11